Status:
RECRUITING
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
Cahaba Medical Care Foundation
Laboratory Corporation of America
Conditions:
Cervical Cancer
Eligibility:
FEMALE
21-65 years
Phase:
NA
Brief Summary
The purpose of the study is to find out if a self-administered (by the patient) Papanicolaou (Pap) smear is as accurate as a traditional Pap smear administered by a healthcare provider.
Detailed Description
Papanicolaou (Pap) smears will be both self-obtained by the patient and obtained by a licensed physician, nurse practitioner, or physician assistant. Specimens will then be collected by the nurse or m...
Eligibility Criteria
Inclusion
- Female of at least 21 years of age and not over 65 presenting who need routine cervical cancer screening per national guidelines.
Exclusion
- prior history of cervical cancer or a positive Pap smear, have had a total hysterectomy (removal of uterus and cervix), or currently enrolled in any other cancer prevention study.
Key Trial Info
Start Date :
April 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04093388
Start Date
April 26 2021
End Date
June 30 2026
Last Update
May 4 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Cahaba Medical Care - West End
Birmingham, Alabama, United States, 35211
2
Cahaba Medical Care - Ensley
Birmingham, Alabama, United States, 35218
3
Cahaba Medical Care
Centreville, Alabama, United States, 35042